Name | tetranor-PGDM |
---|---|
Synonyms |
Cyclopentaneoctanoic acid, 2-(2-carboxyethyl)-3-hydroxy-ε,5-dioxo-, (1R,2R,3S)-
tetranor-prostaglandin D metabolite 8-[(1R,2R,3S)-2-(2-Carboxyethyl)-3-hydroxy-5-oxocyclopentyl]-6-oxooctanoic acid tetranor-prostaglandin A metabolite |
Description | Tetranor-PGDM is an abundant urinary metabolite reflects biosynthesis of prostaglandin D2[1]. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 622.2±50.0 °C at 760 mmHg |
Molecular Formula | C16H24O7 |
Molecular Weight | 328.358 |
Flash Point | 344.1±26.6 °C |
Exact Mass | 328.152191 |
PSA | 128.97000 |
LogP | -1.38 |
Vapour Pressure | 0.0±4.1 mmHg at 25°C |
Index of Refraction | 1.522 |
~50% 70803-91-7 |
Literature: CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; Location in patent: Page/Page column 21 ; |
~% 70803-91-7 |
Literature: CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
~% 70803-91-7 |
Literature: CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
~% 70803-91-7 |
Literature: CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
~% 70803-91-7 |
Literature: CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
~% 70803-91-7 |
Literature: CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
~% 70803-91-7 |
Literature: CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
Precursor 3 | |
---|---|
DownStream 1 | |